Home - Products - Others - Other Targets - D-Fructose-6-phosphate (sodium salt hydrate)

D-Fructose-6-phosphate (sodium salt hydrate)

CAS No. 918149-30-1

D-Fructose-6-phosphate (sodium salt hydrate)( —— )

Catalog No. M34994 CAS No. 918149-30-1

D-Fructose-6-phosphate (sodium salt hydrate) is a sugar intermediate in the glycolytic pathway produced by the isomerization of glucose 6-phosphate by glucose phosphate isomerase, and is used in cancer research.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG 29 Get Quote
500MG 59 Get Quote
1G 86 Get Quote

Biological Information

  • Product Name
    D-Fructose-6-phosphate (sodium salt hydrate)
  • Note
    Research use only, not for human use.
  • Brief Description
    D-Fructose-6-phosphate (sodium salt hydrate) is a sugar intermediate in the glycolytic pathway produced by the isomerization of glucose 6-phosphate by glucose phosphate isomerase, and is used in cancer research.
  • Description
    D-Fructose-6-phosphate (sodium salt hydrate) is a sugar intermediate in the glycolytic pathway produced by the isomerization of glucose 6-phosphate by glucose phosphate isomerase, and is used in cancer research.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    918149-30-1
  • Formula Weight
    340.13
  • Molecular Formula
    C6H15Na2O11P
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    OCC([C@@H](O)[C@H](O)[C@H](O)COP([O-])([O-])=O)=O.[Na+].O.[Na+].O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • 8-epi-Confertin

    The herbs of Inula hupehensis.

  • RGX-104 free Acid

    RGX-104 free Acid is an agonist of potent liver-X nuclear hormone receptor (LXR)?.

  • EZM0414 TFA

    EZM0414 TFA (SETD2-IN-1 TFA) is a SETD2 inhibitor with anticancer and antiproliferative effects for the study of leukemia and immune dysfunction.